Home

At Graviton, we’re enabling a future where disease is a concept of the past. Graviton is a leader in medical research and development.

With our platform's origins in small molecule-based TDI01 pathway modulation (See Our Science), we develop therapeutics to penetrate the central nervous system and address a range of degenerative diseases, including certain cancers, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis other autoimmune diseases and other fibrotic disease.